NCT00601718 2017-05-25Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaUniversity of WashingtonPhase 1/2 Completed29 enrolled 10 charts
NCT00005634 2013-06-19Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT01116154 2010-12-09Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1 Terminated30 enrolled